Curiteva, a Huntsville, AL based technology company, is revolutionizing spinal surgery with the commercial release of its Inspire Porous PEEK HAFUSE Cervical Interbody System, recently FDA-cleared for use.
This ground-breaking system is the world’s first 3D printed, fully interconnected porous PEEK structure, created using Curiteva’s proprietary Fused Filament Fabrication process. Patients everywhere can now benefit from a more effective and minimally invasive cervical interbody fusion procedure.
Curiteva has designed, programmed and built a proprietary, patented 3D printer, utilizing Evonik VESTAKEEP® i4 3DF PEEK high-performance polymer, to create the revolutionary Inspire platform. This innovative platform is set to revolutionize the industry, providing powerful and reliable solutions with its cutting-edge technology.
Dr. Alex Vaccaro, President of Rothman Orthopedic Institute in Philadelphia, is excited about the potential of Curiteva’s 3D printing process and its lattice PEEK architecture. He said, “This technology has the power to revolutionize spine, orthopedic, and neurosurgical procedures that involve biologic implants.”
Dr. Kevin Foley, Chairman of the Semmes-Murphey Neurologic and Spine Institute and professor of neurosurgery, orthopedic surgery and biomedical engineering at the University of Tennessee Health Science Center, is awe-struck by the Inspire porous PEEK technology.
It offers a plethora of advantages such as fully interconnected porosity, modulus of elasticity equivalent to cancellous bone, strong biomechanical properties, radiolucency, and a bioactive surface for osseointegration – making it the ideal interbody implant.
Dr. Randy Dryer of the Central Texas Spine Institute is thrilled to present patients with a new implant, which is enhanced with HAFUSE nano-surface topography. This novel implant is characterised by interconnected porosity, pore size distribution, and nano-surface architecture – features that create the optimal environment for osteoprogenitor cells to promote bone healing (fusion) and reduce the risk of subsidence. It’s truly a revolutionary advancement in spinal implants!
Curiteva’s commitment to developing and investing in disruptive technologies is further exemplified by the introduction of their new 3D printing technology. After years of research and development, Vice President of Emerging Technology, Todd Reith, is proud to present this unique architecture that is set to revolutionize the spine and orthopedics industry.
A full commercial launch of this groundbreaking technology is planned for later this year, giving customers in the United States access to its revolutionary capabilities.
About Curiteva
Curiteva is a technology and manufacturing company that is revolutionizing spine surgery and improving clinical outcomes. Our goal is to build world-class manufacturing, advance research and development, and provide intuitive implant systems. We are dedicated to partnering with providers and suppliers to bring the most innovative and effective solutions to the market, ensuring our customers and their patients have the best care available.